Ranked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients

Vanessa L. Beesley; Alexandra M. Clavarino; Penelope M. Webb; David K. Wyld; Alessandra B. Francesconi; Keith R. Horwood; James D. Doecke; Colleen A. Loos; Adele C. Green

doi:10.1007/s00520-009-0734-z

Ranked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients

Vanessa L. Beesley, Alexandra M. Clavarino, Penelope M. Webb, David K. Wyld, Alessandra B. Francesconi, Keith R. Horwood, James D. Doecke, Colleen A. Loos, Adele C. Green

Research output: Contribution to journal › Article › peer-review

Abstract

Purpose: To examine the importance of possible outcomes of first-line versus repeated chemotherapy to ovarian cancer patients and to compare doctors' treatment intentions with patients' beliefs about cure. Methods: Women with newly diagnosed (74) or relapsed (48) ovarian cancer were prospectively followed over 2 years. The level of importance they ascribed to four chemotherapy outcomes and their beliefs about cure were assessed. Their doctors independently specified intent of successive treatments. Results: Approximately half (54%) of newly diagnosed ovarian cancer patients (65% with residual disease >2 cm and 49% with no or ≤2 cm residual disease) ranked 'tumour shrinkage (or decrease in blood levels of CA125)' as 'most important' during first-line chemotherapy. Approximately two thirds (65-70%) of all women whose disease had relapsed also ranked 'tumour shrinkage' as 'most important' during repeated chemotherapy. Few women (

Original language	English
Pages (from-to)	943-949
Number of pages	6
Journal	Supportive Care in Cancer
Volume	18
Issue number	8
DOIs	https://doi.org/10.1007/s00520-009-0734-z
Publication status	Published - Aug 2010

Keywords

Belief in cure
Chemotherapy
Oncology
Ovarian cancer
Treatment goals and understanding

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00520-009-0734-z

Cite this

@article{55743ef69bbb4304973a7eb39aaae21f,

title = "Ranked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients",

abstract = "Purpose: To examine the importance of possible outcomes of first-line versus repeated chemotherapy to ovarian cancer patients and to compare doctors' treatment intentions with patients' beliefs about cure. Methods: Women with newly diagnosed (74) or relapsed (48) ovarian cancer were prospectively followed over 2 years. The level of importance they ascribed to four chemotherapy outcomes and their beliefs about cure were assessed. Their doctors independently specified intent of successive treatments. Results: Approximately half (54%) of newly diagnosed ovarian cancer patients (65% with residual disease >2 cm and 49% with no or ≤2 cm residual disease) ranked 'tumour shrinkage (or decrease in blood levels of CA125)' as 'most important' during first-line chemotherapy. Approximately two thirds (65-70%) of all women whose disease had relapsed also ranked 'tumour shrinkage' as 'most important' during repeated chemotherapy. Few women (",

keywords = "Belief in cure, Chemotherapy, Oncology, Ovarian cancer, Treatment goals and understanding",

author = "Beesley, {Vanessa L.} and Clavarino, {Alexandra M.} and Webb, {Penelope M.} and Wyld, {David K.} and Francesconi, {Alessandra B.} and Horwood, {Keith R.} and Doecke, {James D.} and Loos, {Colleen A.} and Green, {Adele C.}",

year = "2010",

month = aug,

doi = "10.1007/s00520-009-0734-z",

language = "English",

volume = "18",

pages = "943--949",

journal = "Supportive Care in Cancer",

issn = "0941-4355",

publisher = "Springer Nature",

number = "8",

}

TY - JOUR

T1 - Ranked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients

AU - Beesley, Vanessa L.

AU - Clavarino, Alexandra M.

AU - Webb, Penelope M.

AU - Wyld, David K.

AU - Francesconi, Alessandra B.

AU - Horwood, Keith R.

AU - Doecke, James D.

AU - Loos, Colleen A.

AU - Green, Adele C.

PY - 2010/8

Y1 - 2010/8

N2 - Purpose: To examine the importance of possible outcomes of first-line versus repeated chemotherapy to ovarian cancer patients and to compare doctors' treatment intentions with patients' beliefs about cure. Methods: Women with newly diagnosed (74) or relapsed (48) ovarian cancer were prospectively followed over 2 years. The level of importance they ascribed to four chemotherapy outcomes and their beliefs about cure were assessed. Their doctors independently specified intent of successive treatments. Results: Approximately half (54%) of newly diagnosed ovarian cancer patients (65% with residual disease >2 cm and 49% with no or ≤2 cm residual disease) ranked 'tumour shrinkage (or decrease in blood levels of CA125)' as 'most important' during first-line chemotherapy. Approximately two thirds (65-70%) of all women whose disease had relapsed also ranked 'tumour shrinkage' as 'most important' during repeated chemotherapy. Few women (

AB - Purpose: To examine the importance of possible outcomes of first-line versus repeated chemotherapy to ovarian cancer patients and to compare doctors' treatment intentions with patients' beliefs about cure. Methods: Women with newly diagnosed (74) or relapsed (48) ovarian cancer were prospectively followed over 2 years. The level of importance they ascribed to four chemotherapy outcomes and their beliefs about cure were assessed. Their doctors independently specified intent of successive treatments. Results: Approximately half (54%) of newly diagnosed ovarian cancer patients (65% with residual disease >2 cm and 49% with no or ≤2 cm residual disease) ranked 'tumour shrinkage (or decrease in blood levels of CA125)' as 'most important' during first-line chemotherapy. Approximately two thirds (65-70%) of all women whose disease had relapsed also ranked 'tumour shrinkage' as 'most important' during repeated chemotherapy. Few women (

KW - Belief in cure

KW - Chemotherapy

KW - Oncology

KW - Ovarian cancer

KW - Treatment goals and understanding

U2 - 10.1007/s00520-009-0734-z

DO - 10.1007/s00520-009-0734-z

M3 - Article

C2 - 19777270

SN - 0941-4355

VL - 18

SP - 943

EP - 949

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

IS - 8

ER -

Ranked importance of outcomes of first-line versus repeated chemotherapy among ovarian cancer patients

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this